Last reviewed: June 6, 2026 Last updated: June 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
At 5mg/mL, the same 2mg dose is 40 units
According to the American Diabetes Association, breakthrough studies have demonstrated promising outcomes involving triple-hormone therapy research, highlighting why researchers continue to monitor developments in this field
The negotiated prices were, in most cases, meaningfully below existing Medicare Part D average prices, but the program applies only to a limited set of Medicare drugs and does not extend to the commercial market
Although rare, some reports have indicated that GLP-1 agonists, including semaglutide, could increase the risk of macular edema in people with diabetes